Studyportals
Ph. D. On Campus

Cancer

Newcastle University

36 months
Duration
22100 GBP/year
4327 GBP/year
Unknown
Tuition fee
Unknown
Unknown
Apply date
Unknown
Unknown
Start date

About

Clinicians, scientists and students engaged in Cancer research at Newcastle University share a common purpose: to improve treatment outcomes for patients with cancer. Work covers a broad spectrum - understanding the biological and molecular differences between normal and malignant cells and using this knowledge to develop new anti-cancer drugs.

Overview

Our staff and postgraduate students are based in the Northern Institute for Cancer Research (NICR) or the School of Natural and Environmental Sciences. The NICR incorporates the Newcastle Cancer Centre, a unique collaboration between Cancer Research UK and the North of England Children's Cancer Research Fund. 

The programme

We are a major training base for the next generation of cancer researchers. Our Institute covers many areas of cancer research, including:

  • solid tumours and leukaemias
  • childhood and adult cancers
  • drug discovery and early phase clinical trials

We offer approximately 15 MD, PhD and integrated MRes/PhD studentships each year, including the Newcastle Cancer Centre training programme. Projects in all research areas are available to fully-funded international students. 

Members of our postgraduate community come from a variety of subject backgrounds including biological and biomedical sciences, chemistry, genetics, pharmacy, medicine, dentistry and veterinary medicine.

We hold regular postgraduate seminars which you will be required to attend and where you will deliver presentations. You will also attend and present your data annually at national cancer research meetings and at least one international meeting.

Quality and Ranking

We rank in the top 100 for Medicine - QS World University Rankings by Subject 2019

Research areas

MPhil, PhD and MD supervision is normally available in the following research areas:

Exploratory biology, target and biomarker discovery

Molecular genetic and mechanistic studies are used to identify critical molecular changes in cancer and their relevance to disease development and progression, and to validate these as biomarkers and targets for therapeutic intervention. A wide range of contemporary genomic, bioinformatic, molecular biology, biochemical and cell biology techniques are used. 

Studies focus on haematological malignancies (leukaemia and lymphoma), paediatric solid tumours (neuroblastoma and medulloblastoma), and adult solid tumours (eg breast, ovarian, prostate, bladder and liver cancers).

Biomarker development

We exploit critical molecular defects as biomarkers to enhance disease detection and diagnosis, prediction of disease course, sensitivity to specific drugs and therapeutic monitoring.  We play leading roles in molecular diagnostics, biomarker assessment and therapeutic monitoring for national and international clinical trials.

Drug development

The exploitation of novel targets is achieved by the use of rational drug design, notably the use of structure-based design, in conjunction with medium-throughput screening. Target molecule synthesis and multiple parallel synthesis approaches are used for lead optimisation, and candidate drugs are evaluated in cell-free and whole cell target-based assays.

Clinical trials

Clinical trials (Phase I/II/III) are undertaken in both adults and children. Trials have a strong hypothesis-testing translational research component and are performed under the auspices of national or international research networks (eg CR–UK, Children's Cancer and Leukaemia Group, European Organisation for Research and Treatment of Cancer), as well as directly in collaboration with the pharmaceutical industry.

We are one of the few academic centres in the UK able to undertake this specialist cancer research. Our expert staff, facilities and our close working relationships with the pharmaceutical and biotechnology sectors, and with clinical trials networks, helps us achieve this.

Read more about staff specialisms.

Programme Structure

See Modules tab in the Programme information in our online Prospectus.

Key information

Duration

  • Full-time
    • 36 months
  • Part-time
    • 72 months
    • Flexible

Start dates & application deadlines

We did our best, but couldn't find the next application deadline and start date information online.
More details

There is no application closing date but  specific deadlines for funding may apply.

Delivered

On Campus

Academic requirements

GPA admission requirements GPA
Upper Second Class

Other requirements

General requirements

A 2:1 honours degree, or international equivalent. Further research experience or a master’s degree would be advantageous.

Tuition Fee

To alway see correct tuition fees
  • International

    22100 GBP/year
    Tuition Fee
    Based on the tuition of 22100 GBP per year during 36 months.
  • EU/EEA

    4327 GBP/year
    Tuition Fee
    Based on the tuition of 4327 GBP per year during 36 months.
EU students starting at Newcastle in 2019 and 2020 will pay the UK (Home) tuition fee for the full duration of their course.

Living costs for Newcastle upon Tyne

560 - 991 GBP /month
Living costs

The living costs include the total expenses per month, covering accommodation, public transportation, utilities (electricity, internet), books and groceries.

Funding

See Fees and Funding tab in the Programme information in our online Prospectus.

Studyportals Tip: Students can search online for independent or external scholarships that can help fund their studies. Check the scholarships to see whether you are eligible to apply. Many scholarships are either merit-based or needs-based.

Fresh content

Updated in the last year

Check the official programme website for potential updates.

Our partners

Cancer
-
Newcastle University

Wishlist

Go to your profile page to get personalised recommendations!

Tuition fee settings